within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BJ04_Albiglutide;

model Albiglutide
  extends Pharmacolibrary.Drugs.ATC.A.A10BJ04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BJ04</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Albiglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus to improve glycemic control. It is administered as a once-weekly subcutaneous injection. Albiglutide was approved for use in several countries but was withdrawn from the market in 2018 for commercial reasons, not safety concerns.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following single subcutaneous administration in adults with type 2 diabetes.</p><h4>References</h4><ol><li><p>Brønden, A, et al., &amp; Christensen, MB (2017). Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide. <i>Clinical pharmacokinetics</i> 56(7) 719–731. DOI:<a href=&quot;https://doi.org/10.1007/s40262-016-0499-8&quot;>10.1007/s40262-016-0499-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28050889/&quot;>https://pubmed.ncbi.nlm.nih.gov/28050889</a></p></li><li><p>Bucheit, JD, et al., &amp; Sisson, EM (2020). Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist. <i>Diabetes technology &amp; therapeutics</i> 22(1) 10–18. DOI:<a href=&quot;https://doi.org/10.1089/dia.2019.0185&quot;>10.1089/dia.2019.0185</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31436480/&quot;>https://pubmed.ncbi.nlm.nih.gov/31436480</a></p></li><li><p>Young, MA, et al., &amp; Reinhardt, RR (2014). Clinical pharmacology of albiglutide, a GLP-1 receptor agonist. <i>Postgraduate medicine</i> 126(7) 84–97. DOI:<a href=&quot;https://doi.org/10.3810/pgm.2014.11.2836&quot;>10.3810/pgm.2014.11.2836</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25387217/&quot;>https://pubmed.ncbi.nlm.nih.gov/25387217</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Albiglutide;
